Correction: EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers
Format: | Article |
---|---|
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903464/?tool=EBI |
Similar Items
-
Correction: EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
by: Sandy Leung-Kuen Au, et al.
Published: (2014-01-01) -
EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
by: Si Sun, et al.
Published: (2020-05-01) -
Intermittent High Glucose Elevates Nuclear Localization of EZH2 to Cause H3K27me3-Dependent Repression of KLF2 Leading to Endothelial Inflammation
by: Sumukh Thakar, et al.
Published: (2021-09-01) -
Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent
by: Jun Yang, et al.
Published: (2022-12-01) -
EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
by: Chen Hou, et al.
Published: (2022-10-01)